Target intelligence / Profile preview

RNA, U6 small nuclear 273, pseudogene (RNU6-273P)

Target
RNU6-273P
Molecular classification
Other, pseudogene, small nuclear RNA—snRNA—pseudogene, non-coding RNA pseudogene
01

Overview

RNU6-273P is a pseudogene of the U6 small nuclear RNA (snRNA) gene family in humans[7][8][13][15]. U6 snRNA itself is a highly conserved, uridine-rich RNA essential for the splicing of pre-messenger RNA as part of the spliceosome complex[5][3][14]. However, RNU6-273P does not produce a functional RNA; instead, it is a noncoding remnant, most likely generated through the retrotransposition or duplication of an ancestral U6 snRNA gene[13][15]. Such pseudogenes are common throughout the genome and do not code for proteins or functional RNAs. There is no evidence that RNU6-273P participates in regulatory mechanisms, acts as an RNA decoy, or has any clinical or biological significance[7][8][15]. U6 snRNA, the parental gene, is crucial for splicing and is one of the most conserved snRNAs in the eukaryotic genome[5][3]. U6 pseudogenes, including RNU6-273P, arise through molecular events like retrotransposition, and their sequences are maintained in the genome but generally lack promoter function or expression capacity[13][15]. According to genome databases (GeneCards, NCBI, BioGPS), RNU6-273P is listed as a pseudogene, and there is no evidence of disease association, protein product, or involvement in cellular pathways[7][8]. Most U6 snRNA pseudogenes are presumed to be transcriptionally inactive and nonfunctional[6][7]. Occasionally, some RNA pseudogenes can have regulatory functions through competitive endogenous RNA (ceRNA) activity, but this is not reported for RNU6-273P[4][10]. No reviewed literature links RNU6-273P to human disease, regulatory functions, or drug responses.

Other names
RNU6-273P

Beyond the preview

Go deeper on RNA, U6 small nuclear 273, pseudogene (RNU6-273P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 273, pseudogene (RNU6-273P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call